CTEV (Claritev) Buyback Yield % : 2.78 (As of Apr. 23, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Claritev Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Claritev's current buyback yield was 2.78%.

Claritev Buyback Yield % Historical Data

The historical data trend for Claritev's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Claritev Buyback Yield % Chart

Claritev Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

1.93

3.54

1.63

4.33

Claritev Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															1.63	3.80	4.96	10.08	4.33

Competitive Comparison of Claritev's Buyback Yield %

For the Health Information Services subindustry, Claritev's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Claritev's Buyback Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Claritev's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Claritev's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Claritev Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Claritev's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-10.37	+	0)	/	239.25864
	=	4.33%

Claritev's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (-10.37	+	0)		/	239.25864
	=	4.33%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Claritev Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Claritev's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Claritev Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Claritev Corp (NYSE:CTEV) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7900 Tysons One Place, Suite 400, McLean, VA, USA, 22102

Website

https://www.claritev.com

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Executives

Michael Kim	officer: See Remarks	POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Anthony Jr Colaluca	director	MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
John Michael Prince	director	115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol	officer: SVP, Chief People Officer	115 FIFTH AVE., NEW YORK NY 10003
Mark Tabak	director, officer: Chief Executive Officer	115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal	director	425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head	officer: EVP & Chief Financial Officer	3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris	director
H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p.	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August	director	C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant	officer: President, New Markets	88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein	director, 10 percent owner, officer: Chief Executive Officer	C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017